1.Neonatal Hyperbilirubinemia.
Journal of the Korean Pediatric Society 1986;29(5):1-5
No abstract available.
Hyperbilirubinemia, Neonatal*
2.The Future Path for the JKMA.
Journal of the Korean Medical Association 2003;46(1):3-3
No abstract available.
3.Augmentation Strategies in Obsessive Compulsive Disorder.
Journal of the Korean Society of Biological Psychiatry 1998;5(2):162-165
The serotonin reuptake inhibitors(SRIs) and the serotonin selective reuptake inhibitors(SSRIs) are considered the first choice agents for pharmacologic treatment of obsessive-compulsive disordr(OCD). However, many patients with OCD experience little or no improvement in their symptoms when treated with SRIs or SSRIs. Patients who have experienced a partial or no response to an SRI/SSRI at 10 to 12 weeks are often considered for augmentation strategies. Nearly every class of psychotropic medications has been tried in an open fashion, though augmentation strategies have been somewhat disappointing.
Humans
;
Obsessive-Compulsive Disorder*
;
Serotonin
4.No title in English
Journal of the Korean Medical Association 1997;40(6):778-781
No abstract available.
5.A consideration for legal proceedings about mental evaluation: For the evaluation of disabilty due to mental disorders after head trauma caused by car accidents etc..
Journal of Korean Neuropsychiatric Association 1993;32(2):149-158
No abstract available.
Craniocerebral Trauma*
;
Head*
;
Mental Disorders*
6.Current Status and Future Perspective of PET.
Korean Journal of Nuclear Medicine 2002;36(1):1-7
No abstract available.
7.Current Status and Future Perspective of PET.
Korean Journal of Nuclear Medicine 2002;36(1):1-7
No abstract available.
8.Brunner's Gland Adenoma: Case Report, & Review of Etiopathogenesis and Clinical Features.
Yeungnam University Journal of Medicine 1985;2(1):265-269
No abstract available.
Adenoma*
9.Iohexol myelography using variable sized spinal needles: special reference to side effect incidence.
Journal of the Korean Radiological Society 1992;28(1):42-46
Side effects of iohexol myelography are known to largely depend on the leakage amount of cerebrospinal fluid at the puncture site of the dura. To evaluate the relationship between side effect incidence and spinal needle size and to assess the possibility of performing myelography in outpatients, iohexol myelography was performed in 100 patients(58 inpatients and 42 outpatients) using variable sized needles. A questionaire including presence or absence, duration and degree of various side effect was used for evaluation of side effect. The overall side effect included headache (15%), back pain (14%). Dizziness (9%), and nausea(4%), etc. The incidences of side effects were 28.0% in total, and 16.7%, 23.5%, 26.3%, 46.4%, in patients using 25G, 23G, 22G, 21G spinal needles, retrospectively. The difference of side effect incidence was not significant between male and female. In conclusion, the use of fine spinal needles(25-26G) is recommended to decrease the side effect incidences in myelgraphy. Our findings support the use of fine needle myelography as a safe, less side-effect procedure, not only for in patients but also for out patients.
Back Pain
;
Cerebrospinal Fluid
;
Dizziness
;
Female
;
Headache
;
Humans
;
Incidence*
;
Inpatients
;
Iohexol*
;
Male
;
Myelography*
;
Needles*
;
Outpatients
;
Punctures
;
Retrospective Studies
10.Disorders of the White Blood Cells.
Korean Journal of Pediatrics 2004;47(Suppl 2):S268-S276
No abstract available.
Leukocytes*